Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

A potential link exists between unexplained hormone deficiency, hair loss, and testicular tumors, suggesting thorough screening is needed.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Abatacept may help some people with alopecia areata regrow hair.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Alopecia areata is now understood to be driven by genetic and immune factors.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

PAS III can cause multiple autoimmune diseases with noticeable skin issues.

A 16-year-old boy had pernicious anemia, autoimmune hemolytic anemia, and later developed alopecia areata.

Hypothyroidism may increase the risk of nonmelanoma skin cancer.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Autoimmune diseases cause the immune system to attack the body, and management varies as some are curable and others are not.

Different growth patterns in thyroid tumors are influenced by where cell growth and death occur.

CRH causes hair loss by reducing autophagy and increasing cell death in hair cells.

Tislelizumab can cause cutaneous lupus erythematosus.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.